NCT01111630View on ClinicalTrials.gov

Study of Erythropoietin (EPO) Administration Schedule

PHASE4CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

October 31, 2013

Study Completion Date

January 31, 2014

Conditions

Chronic Renal FailureAnaemia

Interventions

DRUG

recomon (Epoetin Beta)

administer once weekly

DRUG

recomon (Epoetin Beta)

administer three times weekly

Trial Locations (1)

Unknown

NHIC Ilsan Hospital, Seoul

Sponsors

Lead Sponsor

JW Pharmaceutical

All Listed Sponsors

lead

JW Pharmaceutical

INDUSTRY